Search - tctmd.com

Displaying 241 - 260 of 420

Sort: Relevancy | Date

Presentation TCT 2016

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

EFS in the USA: Challenges and Developments (An Investigators Perspective)

Presenter: Andrew Farb, Aaron V. Kaplan, Martin B. Leon

October 31, 2016

Presentation TCT 2016

Early Feasibility Studies in the USA: Early Example With Success

Presenter: Andrew Farb, Aaron V. Kaplan, Steven R. Bailey

October 31, 2016

Presentation TCT 2016

Early Feasibility Studies in USA: Progress Report From the FDA

Presenter: Andrew Farb, Aaron V. Kaplan, Carla M Wiese

October 31, 2016

Presentation TCT 2016

Opportunities and Risks of Data Sharing III: International Consortium Proposal

Presenter: C. Michael Gibson, A. Michael Lincoff, Philip James Devereaux

October 31, 2016

Presentation TCT 2016

Opportunities and Risks of Data Sharing II: ACCESS CV Proposal

Presenter: C. Michael Gibson, A. Michael Lincoff, Manesh R. Patel

October 31, 2016

Presentation TCT 2016

Opportunities and Risks of Data Sharing I: YODA Proposal

Presenter: C. Michael Gibson, A. Michael Lincoff, Harlan Krumholz

October 31, 2016

Presentation TCT 2016

The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective

Presenter: C. Michael Gibson, A. Michael Lincoff, Eric D. Peterson

October 31, 2016

Presentation TCT 2016

Key Note Lecture I. FDA/CDRH State of the Union

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Jeffrey Shuren

October 31, 2016

Presentation TCT 2016

Featured Lecture: The Rationale and Impact of New European Device Regulations

Presenter: Michael J. Mack, Aaron V. Kaplan, Alan G. Fraser

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

Presentation TCT 2016

Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI

Presenter: John A. Bittl, Daniel I. Simon, Glenn N. Levine

October 30, 2016

Presentation TCT 2016

Summary and Rationale For the ESC Guidelines on DAPT Duration After PCI

Presenter: John A. Bittl, Daniel I. Simon, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines) Into Changes in Clinical Practice

Presenter: Roxana Mehran, Pascal Vranckx

October 30, 2016

Presentation TCT 2016

Whats New and What's Controversial in the US and EU Guidelines?

Presenter: Ted Feldman, Allan Schwartz, Catherine M. Otto

October 30, 2016

Presentation TCT 2016

Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, John G. Webb

October 30, 2016

Advertisement

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

EFS in the USA: Challenges and Developments (An Investigators Perspective)

Early Feasibility Studies in the USA: Early Example With Success

Early Feasibility Studies in USA: Progress Report From the FDA

Opportunities and Risks of Data Sharing III: International Consortium Proposal

Opportunities and Risks of Data Sharing II: ACCESS CV Proposal

Opportunities and Risks of Data Sharing I: YODA Proposal

The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective

Key Note Lecture I. FDA/CDRH State of the Union

Featured Lecture: The Rationale and Impact of New European Device Regulations

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI

Summary and Rationale For the ESC Guidelines on DAPT Duration After PCI

The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines) Into Changes in Clinical Practice

Whats New and What's Controversial in the US and EU Guidelines?

Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content